SCHEMBL20291477

SCHEMBL20291477

CC(=O)N[C@H]1C(O)O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AMDHD2 Q9Y303 1/20 0.68
▸ FBP1 P09467 1/20 0.58
▸ MAPK1 P28482 1/20 0.45
▸ IGF2R P11717 4/20 0.44
▸ LGALS3 P17931 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ P2RY2 P41231 1/20 0.40
▸ TAS1R3 Q7RTX0 1/20 0.40
▸ TAS1R1 Q7RTX1 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HK1 P19367 1/20 0.40
▸ HK2 P52789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394667 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL14669223 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL4363197 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL20299968 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL29425232 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL25361382 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL4363206 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL20912983 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL20558753 1.00 AMDHD2 (0.68) AMDHD2FBP1MAPK1IGF2RLGALS3
SCHEMBL14414833 0.96 AMDHD2 (0.62) AMDHD2FBP1MAPK1IGF2RLGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702138-A1 PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL Inbiose N.V. (BE) 2026-03-04 — — EP claimed
EP-4662305-A1 PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC Inbiose N.V. (BE) 2025-12-17 — — EP claimed
CN-120118905-A GlcNAc6P biosensor and application thereof 江南大学 2025-06-10 — — CN claimed
WO-2025074104-A2 BIOMARKERS FOR PROSTATE CANCER ABERYSTWYTH UNIVERSITY (GB) 2025-04-10 — — WO claimed
WO-2024223815-A1 PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL INBIOSE N.V. (BE) 2024-10-31 — — WO claimed
WO-2024165611-A1 PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC INBIOSE N.V. (BE) 2024-08-15 — — WO claimed
EP-4370664-A1 LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES Inbiose N.V. (BE) 2024-05-22 — — EP claimed
EP-4323510-A1 CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES Inbiose N.V. (BE) 2024-02-21 — — EP claimed
EP-4192973-A2 PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES Inbiose N.V. (BE) 2023-06-14 — — EP claimed
EP-4192971-A1 PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL Inbiose N.V. (BE) 2023-06-14 — — EP claimed
EP-4192972-A1 PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL Inbiose N.V. (BE) 2023-06-14 — — EP claimed
CN-115960874-A Corynebacterium glutamicum endogenous GlcNAc6P phosphatase and method for improving GlcNAc yield 山东润德生物科技有限公司 2023-04-14 — — CN claimed
WO-2023285650-A1 LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES INBIOSE N.V. (BE) 2023-01-19 — — WO claimed
WO-2022219188-A1 CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES INBIOSE N.V. (BE) 2022-10-20 — — WO claimed
US-11466300-B2 Method for producing N-Acetyl-D-Glucosamine and/or D-Glucosamine salt by microbial fermentation SUN LAN (CN) 2022-10-11 — — US claimed
WO-2022034076-A2 PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES INBIOSE N.V. (BE) 2022-02-17 — — WO claimed
WO-2022034075-A1 PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL INBIOSE N.V. (BE) 2022-02-17 — — WO claimed
EP-4743567-A1 CELLULAR PRODUCTION OF LACTO-N-TRIOSE (LN3)-CONTAINING OLIGOSACCHARIDES Inbiose N.V. (BE) 2026-05-20 — — EP disclosed
EP-3339858-A1 CORONARY HEART DISEASE BIOMARKER AND APPLICATION THEREOF BGI Shenzhen (CN) 2018-06-27 — — EP disclosed
CN-101553578-A glmS riboswitches, structure-based compound design with glmS riboswitches, and methods and compositions for use of and with glmS riboswitches UNIV YALE (US) 2009-10-07 — — CN disclosed
Send feedback